Skip to main content
Erschienen in: Zeitschrift für Gerontologie und Geriatrie 3/2011

01.06.2011 | Beiträge zum Themenschwerpunkt

Diabetes und kardiovaskuläre Erkrankungen im Alter

verfasst von: Dr. A. Bahrmann, P. Bahrmann, A. Zeyfang, P. Oster

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Behandlung kardiovaskulärer Erkrankungen bei Menschen mit Diabetes mellitus bedarf insbesondere im hohen Lebensalter einer individuellen Nutzen-Risiko-Analyse. Eine Übertherapie der Hyperglykämie im Sinne einer zu strengen Stoffwechseleinstellung (HbA1c-Wert <6%) kann zu einer erhöhten Mortalität führen. In der Regel sollte der angestrebte HbA1c-Wert bei geriatrischen Patienten mit Diabetes mellitus zwischen 7 und 8% liegen.
Literatur
1.
Zurück zum Zitat Wannamethee SG, Shaper AG, Whincup PH et al (2011) Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 171(5):404–410PubMedCrossRef Wannamethee SG, Shaper AG, Whincup PH et al (2011) Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors. Arch Intern Med 171(5):404–410PubMedCrossRef
2.
Zurück zum Zitat Behrens M, Dörr R, Eckert S et al (2010) Diabetes mellitus und Herz. Diabetol Stoffwechsel 5:122–126CrossRef Behrens M, Dörr R, Eckert S et al (2010) Diabetes mellitus und Herz. Diabetol Stoffwechsel 5:122–126CrossRef
3.
Zurück zum Zitat Malmberg K, Yusuf S, Gerstein HC et al (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102(9):1014–1019PubMed Malmberg K, Yusuf S, Gerstein HC et al (2000) Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction: results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry. Circulation 102(9):1014–1019PubMed
4.
Zurück zum Zitat Erdmann E (2006) Klinische Kardiologie. Springer, Berlin Heidelberg New York Erdmann E (2006) Klinische Kardiologie. Springer, Berlin Heidelberg New York
5.
Zurück zum Zitat American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8:651–745CrossRef American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8:651–745CrossRef
6.
Zurück zum Zitat UK Diabetes Prospective Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk for complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef UK Diabetes Prospective Study Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk for complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853CrossRef
7.
Zurück zum Zitat Adler AL, Stevens RJ, Manley SE et al (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63(1):225–232PubMedCrossRef Adler AL, Stevens RJ, Manley SE et al (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63(1):225–232PubMedCrossRef
8.
Zurück zum Zitat Beckett NS, Peters R, Fletcher AE et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898PubMedCrossRef Beckett NS, Peters R, Fletcher AE et al (2008) Treatment of hypertension in patients 80 years of age or older. N Engl J Med 358:1887–1898PubMedCrossRef
9.
Zurück zum Zitat Deutsche Diabetes-Gesellschaft (DDG). http://www.deutsche-diabetes-gesellschaft.de/redaktion/mitteilungen/leitlinien/Uebersicht_leitlinien_evidenzbasiert.php. Zugegriffen: 27.03.11 Deutsche Diabetes-Gesellschaft (DDG). http://​www.​deutsche-diabetes-gesellschaft.​de/​redaktion/​mitteilungen/​leitlinien/​Uebersicht_​leitlinien_​evidenzbasiert.​php.​ Zugegriffen: 27.03.11
10.
Zurück zum Zitat Gaede P et al (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes mellitus. N Engl J Med 358:580–591PubMedCrossRef Gaede P et al (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes mellitus. N Engl J Med 358:580–591PubMedCrossRef
11.
Zurück zum Zitat Zeyfang A, Bahrmann A, Wernecke J (2010) Praxisleitlinie Diabetes mellitus im Alter. Diabetol Stoffwechsel 5:166–171CrossRef Zeyfang A, Bahrmann A, Wernecke J (2010) Praxisleitlinie Diabetes mellitus im Alter. Diabetol Stoffwechsel 5:166–171CrossRef
12.
Zurück zum Zitat Hader C et al (2004) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. In: Scherbaum WA, Kiess W (Hrsg) Evidenzbasierte Diabetes-Leitlinie DDG. Diabetes Stoffwechsel 13:31–56 Hader C et al (2004) Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Alter. In: Scherbaum WA, Kiess W (Hrsg) Evidenzbasierte Diabetes-Leitlinie DDG. Diabetes Stoffwechsel 13:31–56
13.
Zurück zum Zitat Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348(5):383–393PubMedCrossRef Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348(5):383–393PubMedCrossRef
14.
Zurück zum Zitat Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481–489PubMedCrossRef Currie CJ, Peters JR, Tynan A et al (2010) Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet 375:481–489PubMedCrossRef
15.
Zurück zum Zitat Miller ME, ACCORD Investigators (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444PubMedCrossRef Miller ME, ACCORD Investigators (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444PubMedCrossRef
16.
Zurück zum Zitat Whitmer RA et al (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572PubMedCrossRef Whitmer RA et al (2009) Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 301:1565–1572PubMedCrossRef
17.
Zurück zum Zitat Ziegler D, Gries FA, Spüler M, Lessmann F (1992) The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 6(1):49–57PubMedCrossRef Ziegler D, Gries FA, Spüler M, Lessmann F (1992) The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group. J Diabetes Complications 6(1):49–57PubMedCrossRef
18.
Zurück zum Zitat Young LH, Wackers FJ, Chyun DA, DIAD Investigators et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD Study: a randomized controlled trial. JAMA 301:1547–1555PubMedCrossRef Young LH, Wackers FJ, Chyun DA, DIAD Investigators et al (2009) Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD Study: a randomized controlled trial. JAMA 301:1547–1555PubMedCrossRef
19.
Zurück zum Zitat Ryden L, Standl E et al (2007) ESC Clinical Practice Guidelines: diabetes, pre-diabetes and cardiovascular diseases. executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88–136PubMedCrossRef Ryden L, Standl E et al (2007) ESC Clinical Practice Guidelines: diabetes, pre-diabetes and cardiovascular diseases. executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88–136PubMedCrossRef
20.
Zurück zum Zitat Norhammar A, Malmberg K, Diderholm E et al (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43(4):585–591PubMedCrossRef Norhammar A, Malmberg K, Diderholm E et al (2004) Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol 43(4):585–591PubMedCrossRef
21.
Zurück zum Zitat Bach RG, Cannon CP, Weintraub WS et al (2005) The effect of routine, early invasive management on outcome of elderly patients with non-ST segment elevation acute coronary syndromes. Ann Intern Med 141:186–195 Bach RG, Cannon CP, Weintraub WS et al (2005) The effect of routine, early invasive management on outcome of elderly patients with non-ST segment elevation acute coronary syndromes. Ann Intern Med 141:186–195
22.
Zurück zum Zitat Schoenenberger AW, Radovanovic D, Stauffer JC et al (2008) Acute Myocardial Infarction in Switzerland Plus Investigators. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J Am Geriatr Soc 56:510–518PubMedCrossRef Schoenenberger AW, Radovanovic D, Stauffer JC et al (2008) Acute Myocardial Infarction in Switzerland Plus Investigators. Age-related differences in the use of guideline-recommended medical and interventional therapies for acute coronary syndromes: a cohort study. J Am Geriatr Soc 56:510–518PubMedCrossRef
23.
Zurück zum Zitat Birkemeyer R, Rillig A, Treusch F et al (2011) Outcome and treatment quality of transfer primary percutaneous intervention in older patients with acute ST-elevation myocardial infarction (STEMI). Arch Gerontol Geriatr (Epub ahead of print) Birkemeyer R, Rillig A, Treusch F et al (2011) Outcome and treatment quality of transfer primary percutaneous intervention in older patients with acute ST-elevation myocardial infarction (STEMI). Arch Gerontol Geriatr (Epub ahead of print)
24.
Zurück zum Zitat Berghe G van den, Wilmer A, Hermans G et al (2006) Insulin therapy in the medical ICU. N Engl J Med 354(5):449–461PubMedCrossRef Berghe G van den, Wilmer A, Hermans G et al (2006) Insulin therapy in the medical ICU. N Engl J Med 354(5):449–461PubMedCrossRef
25.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 137(2):263–272PubMedCrossRef Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 137(2):263–272PubMedCrossRef
26.
Zurück zum Zitat UK Diabetes Prospective Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865CrossRef UK Diabetes Prospective Study Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865CrossRef
27.
Zurück zum Zitat Baltes PB, Mayer KU (eds) (1999) The Berlin Aging Study: Aging from 70 to 100. Cambridge University Press, New York. http://www.base-berlin.mpg.de. Zugegriffen: 23.03.2011) Baltes PB, Mayer KU (eds) (1999) The Berlin Aging Study: Aging from 70 to 100. Cambridge University Press, New York. http://​www.​base-berlin.​mpg.​de.​ Zugegriffen: 23.03.2011)
28.
Zurück zum Zitat Hajjar ER, Cafiero AC, Hanlon JC (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacotherap 5:345–351CrossRef Hajjar ER, Cafiero AC, Hanlon JC (2007) Polypharmacy in elderly patients. Am J Geriatr Pharmacotherap 5:345–351CrossRef
29.
Zurück zum Zitat Boyd CM et al (2005) Clinical Practice Guidelines and quality of care for older patients with multiple co-morbid diseases. JAMA 294:716–724PubMedCrossRef Boyd CM et al (2005) Clinical Practice Guidelines and quality of care for older patients with multiple co-morbid diseases. JAMA 294:716–724PubMedCrossRef
30.
Zurück zum Zitat Sirious C et al (2008) Underuse of cardioprotective treatment by the elderly with type 2 diabetes. Diabetes Metabol 34:169–176CrossRef Sirious C et al (2008) Underuse of cardioprotective treatment by the elderly with type 2 diabetes. Diabetes Metabol 34:169–176CrossRef
Metadaten
Titel
Diabetes und kardiovaskuläre Erkrankungen im Alter
verfasst von
Dr. A. Bahrmann
P. Bahrmann
A. Zeyfang
P. Oster
Publikationsdatum
01.06.2011
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 3/2011
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-011-0216-z

Weitere Artikel der Ausgabe 3/2011

Zeitschrift für Gerontologie und Geriatrie 3/2011 Zur Ausgabe

Beiträge zum Themenschwerpunkt

Gefäßalterung

Mitteilungen des BV Geriatrie

Mitteilungen des BV Geriatrie